Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q4 FY24 results · Jan–Mar 2024

Insecticides (India) reported revenue from operations of ₹272.50 crore (down 9.7% from Q4 FY23) and net profit of ₹7.76 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations272.50301.90−9.7%357.94−23.9%
Other income4.530.4111x1.22+271.9%
Total income277.04302.31−8.4%359.16−22.9%
Profit before share of associates & JVs and tax3.82(38.98)Turned profit17.03−77.6%
Share of profit/(loss) of associates & JVs(0.05)(0.34)0.05
Net profit for the period7.76(29.30)Turned profit12.31−36.9%
EPS, basic (₹)2.62(9.90)Turned profit4.16−37.0%
Net margin (%)2.8-9.73.4

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations272.50301.90−9.7%357.94−23.9%
Other income4.560.4111x1.23+269.1%
Total income277.06302.31−8.4%359.18−22.9%
Profit before tax4.15(39.03)Turned profit17.04−75.6%
Net profit for the period8.08(29.01)Turned profit12.27−34.2%
EPS, basic (₹)2.73(9.80)Turned profit4.14−34.1%
Net margin (%)3.0-9.63.4
Consolidated
Filed with BSE
19 Jul 2024, 14:24 IST
Board meeting
28 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
19 Jul 2024, 14:24 IST
Board meeting
28 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE